These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3367387)

  • 1. Meeting highlights: adjuvant therapy for breast cancer.
    Glick JH
    J Natl Cancer Inst; 1988 Jun; 80(7):471-5. PubMed ID: 3367387
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic adjuvant therapy for node-negative breast cancer: proven or premature?
    Pritchard KI
    Ann Intern Med; 1989 Jul; 111(1):1-4. PubMed ID: 2660644
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of adjuvant endocrine therapy in primary breast cancer.
    Baum M; Ebbs SR
    Recent Results Cancer Res; 1989; 115():136-43. PubMed ID: 2696026
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant tamoxifen therapy and receptor levels.
    Stewart HJ; Prescott R
    Lancet; 1985 Mar; 1(8428):573. PubMed ID: 2857915
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tamoxifen-induced progesterone receptors in breast tumors].
    Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
    Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant systemic therapy for early breast cancer.
    Lancet; 1992 Jan; 339(8784):27. PubMed ID: 1345955
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.
    A'Hern RP; Wilson AJ; Baum M
    Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a place for adjuvant endocrine therapy of breast cancer?
    Meakin JW
    Recent Results Cancer Res; 1980; 71():178-84. PubMed ID: 7367731
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
    Rosso R; Boccardo F; Brema F; Sertoli MR; Amoroso D; Bertelli G; Pronzato P
    Anticancer Res; 1989; 9(4):1153-6. PubMed ID: 2817796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant systemic therapy of breast cancer.
    Lippman ME
    Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant therapy of primary breast cancer. Closing summary and outlook.
    Glick JH
    Recent Results Cancer Res; 1989; 115():283-92. PubMed ID: 2696039
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
    Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
    Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
    Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen therapy in advanced breast cancer with positive estrogen receptors in postmenopausal women.
    Bono A; Fariselli G; Bettoni I; Alloisio M; Nicoli N; Di Pietro S
    Tumori; 1982 Apr; 68(2):143-7. PubMed ID: 7123673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause].
    Kurz C; Scholten C; Zielinski C; Czerwenka K; Kubista E; Spona J; Sevelda P
    Dtsch Med Wochenschr; 1992 Dec; 117(51-52):1943-6. PubMed ID: 1478168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine therapy of breast cancer].
    Jonat W; Maass H
    Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.